Dr. Springs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 University Blvd
Suite 3005
Indianapolis, IN 46202Phone+1 317-274-8937Fax+1 317-274-2727
Education & Training
- Duke University HospitalFellowship, Cornea, External Diseases, and Refractive Surgery, 1998 - 1999
- Indiana University School of MedicineResidency, Ophthalmology, 1995 - 1998
- Ascension St Vincent Hospital IndianapolisInternship, Transitional Year, 1994 - 1995
- Medical University of South CarolinaClass of 1994
Certifications & Licensure
- IN State Medical License 1995 - 2025
- NC State Medical License 2021 - 2025
- WV State Medical License 2000 - 2003
- MA State Medical License 1999 - 2002
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Dry Eye Assessment and Management Study Start of enrollment: 2014 Nov 01
- Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease Start of enrollment: 2016 Jun 01
- Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Position Start of enrollment: 2020 May 04
Publications & Presentations
PubMed
- 1 citations0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-M...Gabriel Sosne, Hynda K Kleinman, Clark Springs, Robert Hollis Gross, Jihye Sung
International Journal of Molecular Sciences. 2022-12-29 - 1 citationsCanonical Grading Scales of Corneal and Conjunctival Staining Based on Psychophysical and Physical AttributesTrefford Simpson, Carolyn G. Begley, Ping Situ, Yunwei Feng, J. Daniel Nelson
Translational Vision Science & Technology. 2021-08-02 - 39 citationsOcular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.Gregory Katz, C. L. Springs, E. Randy Craven, Michela Montecchi-Palmer
Clinical Ophthalmology. 2010-11-03
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: